Non-Pioglitazone Antihyperglycemic Agents for Secondary Prevention of Stroke in Type II Diabetes or Pre-Diabetes: Clinical Effectiveness and Cost-Effectiveness

Details

Files

Project Line:

Reference List

Project Sub Line:

Summary of Abstracts

Project Number:

RB1485-000

Question

What is the clinical effectiveness of non-pioglitazone antihyperglycemic agents for secondary prevention of stroke in patients with type II diabetes or pre-diabetes?
What is the cost-effectiveness of non-pioglitazone antihyperglycemic agents for secondary prevention of stroke in patients with type II diabetes or pre-diabetes?

Key Message

Four non-randomized studies (all secondary analyses of clinical trial data) were identified regarding the clinical effectiveness of non-pioglitazone antihyperglycemic agents for secondary prevention of stroke in patients with type II diabetes or pre-diabetes. No relevant literature was identified regarding the cost-effectiveness of non-pioglitazone antihyperglycemic agents for secondary prevention of stroke in patients with type II diabetes or pre-diabetes.

Files

Non-Pioglitazone Antihyperglycemic Agents for Secondary Prevention of Stroke in… View PDF

Last Updated : May 13, 2020